Medicine Man Technologies Inc (OTCMKTS:MDCL) Director Justin Dye bought 3,500,000 shares of the company’s stock in a transaction that occurred on Sunday, June 16th. The shares were bought at an average cost of $2.00 per share, for a total transaction of $7,000,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Justin Dye also recently made the following trade(s):
- On Wednesday, June 5th, Justin Dye bought 1,500,000 shares of Medicine Man Technologies stock. The shares were bought at an average cost of $2.00 per share, for a total transaction of $3,000,000.00.
Medicine Man Technologies stock opened at $3.01 on Friday. Medicine Man Technologies Inc has a 52 week low of $1.06 and a 52 week high of $4.17. The business’s 50-day moving average price is $3.10 and its 200 day moving average price is $2.88.
Medicine Man Technologies Company Profile
Medicine Man Technologies, Inc provides cultivation consulting services for cannabis growing technologies and methodologies. The company also provides licensing and seminar services. In addition, it engages in retail operations of cannabis products. The company was founded in 2014 and is based in Denver, Colorado.
See Also: How to Use a Moving Average for Trading
Receive News & Ratings for Medicine Man Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicine Man Technologies and related companies with MarketBeat.com's FREE daily email newsletter.